Loading…
French perfume maker and distributor that develops and markets fragrances under licensed fashion and lifestyle brand names.
French perfume maker and distributor that develops and markets fragrances under licensed fashion and lifestyle brand names.
Holds licences to make and sell fragrances for fashion and luxury brands, paying the brand owners royalties on sales, so growth depends on renewing licences and winning new ones. A few brands account for much of sales, and the founders, Philippe Benacin and Jean Madar, control it through a holding company.
In one line: A licensed-brand fragrance house like Coty's prestige arm.
Moat: narrow (brand, distribution). Long-term exclusive licenses with fashion brands and global distribution network, but license renewal risk.
Headquarters: Paris, France · Founded: 1982 · Employees: 378
Size Interparfums (ITP.PA) is a France Consumer Staples company (Household/Personal Care) with a market value of $3.65B, the 78th largest of 206 France companies the cockpit tracks. Shares closed at €37.02 on 6 Nov 2026.
Performance Over six months the shares gained 71.8%, against -1.7% for the median peer and -0.4% for the France market (cap-weighted) — 2nd highest of 21 in its peer set.
Growth Revenue fell 4.2% over the last twelve months (peer median +3.9%); the operating margin is 18.3% (peer median 11.6%).
Valuation It trades at 27.5× forward earnings against a peer median of 18.5× (5th most expensive of 20).
Price implies For today's price to make sense, revenue must grow about 16% a year for seven years (Req g). Recent delivered growth is +20%, so the hurdle is -4 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 5.5 points above its cost of capital (10.7% WACC).
Next results Next results expected around 24 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | €867M | €899M | €880M | €798M | €707M |
| Revenue growth | — | +2% | +10% | +13% | — |
| Gross profit | €551M | €565M | €561M | €516M | €458M |
| EBITDA | €179M | €202M | €195M | €182M | €156M |
| Net income | €119M | €127M | €130M | €119M | €99.5M |
| Free cash flow | €166M | €127M | €101M | €72.1M | €52.4M |
| Capital expenditure | €8.44M | €40.5M | €20.5M | €54.0M | €77.8M |
| Total debt | n/a | €152M | €147M | €138M | €160M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Interparfums ITP.PA | $3.65B | +72% | -4% | 18% | 27.5× | 15.9% |
| Coty COTY | $3.57B | +64% | -1% | 5% | 13.3× | 11.3% |
| Puig Brands PUIG.MC | $12.5B | +16% | +4% | 16% | 17.9× | -3.0% |
| L'Oreal OR.PA | $268B | +25% | +3% | 21% | 32.8× | 18.1% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | ITP.PA | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +22.8% | +1.7% | 2nd highest of 21 |
| 6-month return | +71.8% | -1.7% | 2nd highest of 21 |
| Distance from 52-week high | -0.4% | -21.9% | highest of 21 |
| Revenue growth (TTM) | -4.2% | +3.9% | 2nd lowest of 21 |
| Operating margin | 18.3% | 11.6% | 8th highest of 21 |
| Forward P/E | 27.5× | 18.5× | 5th most expensive of 20 |
| Growth the price implies (Req g, 7 yrs) | 15.9% | -0.1% | 4th most demanding of 18 |
| Growth delivered (Del g) | +19.6% | +4.5% | 5th highest of 18 |
| Hurdle (Req g minus delivered) | -3.7 pp | -2.4 pp | 8th least demanding of 18 |
| ROIC minus cost of capital | +5.5 pp | +5.1 pp | 9th highest of 20 |
| EV / EBITDA | 18.3× | 11.3× | 5th most expensive of 16 |
| Net debt / EBITDA | 0.1× | -0.8× | 4th most indebted of 17 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Interparfums ITP.PA | France | $3.65B | +72% | -4% | 18% | 27.5× | 15.9% | +19.6% |
| Coty COTY | United States | $3.57B | +64% | -1% | 5% | 13.3× | 11.3% | +4.6% |
| Rohto Pharmaceutical 4527.T | Japan | $3.97B | +17% | +10% | 12% | 16.7× | -2.1% | +13.7% |
| Kobayashi Pharmaceutical 4967.T | Japan | $3.29B | +20% | +4% | 6% | 50.2× | 17.6% | +1.9% |
| Hengan Int'l 1044.HK | Hong Kong | $3.28B | -16% | +2% | 11% | 9.1× | -8.8% | -0.1% |
| Lion 4912.T | Japan | $3.19B | +21% | +6% | 8% | 19.9× | -2.4% | +3.5% |
| Proya Cosmetics 603605.SS | China | $2.97B | -19% | +2% | 13% | 11.1× | -4.8% | +23.1% |
| Giant Biogene 2367.HK | Hong Kong | $2.76B | -34% | -10% | 32% | 9.7× | -8.0% | +34.9% |
| Colgate-Palmolive (India) COLPAL.NS | India | $4.83B | -23% | +9% | 28% | 32.2× | 30.8% | +4.5% |
| Cupid CUPID.NS | India | $4.83B | +158% | +122% | 34% | n/a | n/a | n/a |
| Mao Geping Cosmetics 1318.HK | Hong Kong | $4.92B | -28% | +32% | 31% | 15.0× | 4.7% | +41.1% |
| Winner Medical 300888.SZ | China | $2.69B | -2% | +4% | 11% | 20.9× | -4.3% | -2.6% |
| Reynolds Consumer Products REYN | United States | $5.08B | +10% | +2% | 14% | 14.6× | -0.2% | +2.7% |
| Gillette India GILLETTE.NS | India | $2.56B | -7% | +8% | 28% | 33.0× | 16.0% | +13.0% |
| LG H&h 051900.KS | South Korea | $2.56B | -8% | -3% | 3% | 18.5× | -0.1% | -4.1% |
| Procter & Gamble Hygiene & Health Care PGHH.NS | India | $2.40B | -29% | -2% | 24% | 27.3× | 15.4% | +7.4% |
| Amorepacific 090430.KS | South Korea | $6.03B | -1% | +10% | 9% | 23.8× | 4.0% | -0.8% |
| Softcare 2698.HK | Hong Kong | $2.20B | -5% | +25% | 25% | 14.4× | 8.7% | +20.9% |
| KOSE 4922.T | Japan | $2.16B | +7% | +3% | 4% | 27.2× | n/a | n/a |
| Cosmax 192820.KS | South Korea | $2.13B | +21% | +16% | 8% | 16.6× | n/a | n/a |
| Pola Orbis 4927.T | Japan | $1.96B | +8% | +1% | 10% | 28.8× | -3.1% | -0.7% |